Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

The development of COVID-19 syndrome in anticoagulated patients, and especially their admission to intensive-care units with acute severe respiratory syndrome (SARS-CoV-2), expose them to specific problems related to their therapy, in addition to those associated with the acute viral infection. Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Sophie, Paoletti, Oriana, Giorgi-Pierfranceschi, Matteo, Pan, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
IM-Point of view
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157827/
https://www.ncbi.nlm.nih.gov/pubmed/32297089
http://dx.doi.org/10.1007/s11739-020-02331-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157827/
https://www.ncbi.nlm.nih.gov/pubmed/32297089
http://dx.doi.org/10.1007/s11739-020-02331-1

Ejemplares similares